Protective and detrimental immunity: Lessons from stiff person syndrome and multiple sclerosis

Acta Neurologica Scandinavica

Volumn 120, Issue SUPPL. 189, 2009, Pages 22-26

  Holmoy T ^a,b   Skorstad, G ^b   Hestvik, A L K ^a   Alvik, K M J ^a   Vartdal, F ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Glatiramer acetate; Multiple sclerosis; Stiff person syndrome; T cells

Indexed keywords

ANTIBODY; ANTIGEN; GLATIRAMER; GLUTAMATE DECARBOXYLASE 65;

ARTICLE; BLOOD; BRAIN; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOPATHOGENESIS; MIGRATION; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; STIFF MAN SYNDROME; T LYMPHOCYTE;

EID: 67651247647     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01207.x     Document Type: Article

References (21)

1. Galea I, Bechmann I, Perry VH. What is immune privilege (not)? Trends Immunol 2007 28 : 12 18.
2. Lassmann H. The pathology of multiple sclerosis and its evolution. Philos Trans R Soc Lond B Biol Sci 1999 354 : 1635 40.
3. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991 28 : 254 60.
4. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 1999 5 : 49 55.
5. Ziv Y, Ron N, Butovsky O et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 2006 9 : 268 75.
6. Hohlfeld R, Kerschnsteiner M, Stadelmann C, Lassmann H, Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol Sci 2006 27 (Suppl. 1 1 7.
7. Holmoy T. Immunopathogenesis of multiple sclerosis: concepts and controversies. Acta Neurol Scand Suppl 2007 187 : 39 45.
8. De Camiili A, Thomas R, Cofiell F et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J Exp Med 1993 178 : 2219 23.
9. Murinson BB, Guarnaccia JB. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology 2008 71 : 1938 9.
10. Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 2007 61 : 544 51.
11. Ziemssen T, Schrempf W. Glatiramer acetate: mechanisms of action in multiple sclerosis. Int Rev Neurobiol 2007 79 : 537 70.
12. Skorstad G, Hestvik AL, Torjesen P et al. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence. Eur J Neurol 2008 15 : 973 80.
13. Ulvestad E, Williams K, Bo L, Trapp B, Antel J, Mork S. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology 1994 82 : 535 41.
14. Storstein A, Vedeler CA. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects. Adv Clin Chem 2007 44 : 143 85.
15. Hiemstra HS, Schloot NC, Van Veelen PA et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001 98 : 3988 91.
16. Skulina C, Schmidt S, Dornmair K et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 2004 101 : 2428 33.
17. Skorstad G, Hestvik AL, Vartdal F, Holmoy T. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J Autoimmun 2009 32 : 24 32.
18. Jabri B, Sollid LM. Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol 2006 3 : 516 25.
19. Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T. Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid. Mult Scler 2008 14 : 749 58.
20. Krumbholz M, Theil D, Derfuss E et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005 201 : 195 200.
21. Cox AL, Thompson SA, Jones JL et al. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur J Immunol 2005 35 : 3332 42.